D. Larocque

发表

Gene Therapy of Multiple Sclerosis and in CNS Autoimmune Mouse Models

D. Larocque, J. Bergeron, Daniel Larocque, 2006 .

The p53 Tumor Suppressor Is Stabilized by Inhibitor of Growth 1 (ING1) by Blocking Polyubiquitination

S. Richard, A. von Deimling, K. Riabowol, 2011, PloS one.

ImmunityResponse Leading to Enhanced Adaptive Transient Localized Innate Immune Agonist-Based Adjuvant System, Induces a AS04, an Aluminum Salt- and TLR4

H. Carlsen, A. Didierlaurent, Francesca, 2009 .

Transient Localized Innate Immune Agonist-Based Adjuvant System, Induces a AS04, an Aluminum Salt- and TLR4

H. Carlsen, A. Didierlaurent, Francesca, 2009 .

Combined Flt3L/TK Gene Therapy Induces Immunological Surveillance Which Mediates an Immune Response Against a Surrogate Brain Tumor Neoantigen.

P. Lowenstein, Chunyan Liu, M. Castro, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Exogenous fms-like tyrosine kinase 3 ligand overrides brain immune privilege and facilitates recognition of a neo-antigen without causing autoimmune neuropathology

P. Lowenstein, James F Curtin, M. Castro, 2010, Proceedings of the National Academy of Sciences.

Pulmonary-Resident Memory Lymphocytes: Pivotal Orchestrators of Local Immunity Against Respiratory Infections

K. Dhaliwal, M. Chabaud-Riou, R. O’Connor, 2021, Frontiers in Immunology.

High-Capacity Adenovirus Vector-Mediated Anti-Glioma Gene Therapy in the Presence of Systemic Antiadenovirus Immunity

P. Lowenstein, M. Castro, W. Xiong, 2008, Journal of Virology.

High-Capacity Adenovirus Vector-Mediated Anti-Glioma Gene Therapy in the Presence of Systemic Antiadenovirus Immunity

P. Lowenstein, M. Castro, W. Xiong, 2008, Journal of Virology.

One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications.

C. Barcia, P. Lowenstein, Chunyan Liu, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Improved factor VIII variants for gene therapy

C. Barcia, P. Lowenstein, Chunyan Liu, 2022 .

Protection of p27Kip1 mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation

Michelle S. Scott, S. Richard, A. Galarneau, 2005, Nature Neuroscience.

AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity1

Arnaud M. Didierlaurent, Sandra Morel, H. Carlsen, 2009, The Journal of Immunology.

Nuclear Retention of MBP mRNAs in the Quaking Viable Mice

S. Richard, P. Lasko, G. Almazan, 2002, Neuron.

Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer’s disease-related pathology

Jean-Philippe Michaud, S. Rivest, C. Cluff, 2013, Proceedings of the National Academy of Sciences.

11 Evolutionary Origins of the Brain's Immune Privilege. Implications for Novel Therapeutic Approaches: Gene Therapy

C. Barcia, P. Lowenstein, M. Castro, 2008 .

Tyrosine Phosphorylation of Sam68 by Breast Tumor Kinase Regulates Intranuclear Localization and Cell Cycle Progression*

K. Lukong, S. Richard, A. Tyner, 2005, Journal of Biological Chemistry.

Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer.

S. Richard, J Pilotte, D Larocque, 2001, Genes & development.

Whole‐blood cytokine secretion assay as a high‐throughput alternative for assessing the cell‐mediated immunity profile after two doses of an adjuvanted SARS‐CoV‐2 recombinant protein vaccine candidate

M. McElrath, P. Goepfert, C. Gerard, 2022, Clinical & translational immunology.

Evaluation of novel synthetic TLR7/8 agonists as vaccine adjuvants.

J. St-Jean, D. Larocque, J. Baldridge, 2016, Vaccine.

QUAKING KH Domain Proteins as Regulators of Glial Cell Fate and Myelination

S. Richard, D. Larocque, Daniel Larocque, 2005, RNA biology.

Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.

J. Boulais, A. Didierlaurent, Anne-Marie Lanteigne, 2015, Journal of immunological methods.

Combined Flt3L/TK gene therapy induces immunological surveillance which mediates an immune response against a surrogate brain tumor neoantigen.

P. Lowenstein, Chunyan Liu, M. Castro, 2011, Molecular Therapy.

Endoplasmic reticulum stress response and bile acid signatures associate with multi-strain seroresponsiveness during elderly influenza vaccination

V. Narang, M. Poidinger, A. Larbi, 2021, iScience.

The QKI-6 and QKI-7 RNA Binding Proteins Block Proliferation and Promote Schwann Cell Myelination

S. Richard, G. Almazan, M. Loignon, 2009, PloS one.

Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brain.

P. Lowenstein, James F Curtin, Chunyan Liu, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.